1
|
Rehbein S, Visser M, Hamel D, Reindl H. Correction to: Occurrence of the giant liver fluke, Fascioloides magna, in sympatric wild ungulates in one area in the Upper Palatinate Forest (northeastern Bavaria, Germany). Parasitol Res 2021; 120:1521. [PMID: 33615413 DOI: 10.1007/s00436-021-07090-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- S Rehbein
- Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Walchenseestr 8-12, 83101, Rohrdorf, Germany.
| | - M Visser
- Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Walchenseestr 8-12, 83101, Rohrdorf, Germany
| | - D Hamel
- Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Walchenseestr 8-12, 83101, Rohrdorf, Germany
| | - H Reindl
- Tierärztliche Fachpraxis für Kleintiere, Schießtrath 12, 92709, Moosbach, Germany
| |
Collapse
|
2
|
Timmermann W, Illert B, Reindl H, Rückle-Lanz H, Wilhelm M, Hensel F, Vollmers HP, Müller-Hermelink HK, Coquoz D, Thiede A. Prognostic effect of CD55 SC-1 in gastric carcinoma (GC) and survival after treatment with the monoclonal antibody SC-1. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- W. Timmermann
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - B. Illert
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - H. Reindl
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - H. Rückle-Lanz
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - M. Wilhelm
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - F. Hensel
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - H. P. Vollmers
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - H. K. Müller-Hermelink
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - D. Coquoz
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| | - A. Thiede
- University Surgical Clinic, University of Würzburg, Würzburg, Germany; Dept. of Internal Medicine, University of Würzburg, Würzburg, Germany; OncoMab GmbH, Würzburg, Germany; Pathology Institute, University of Würzburg, Würzburg, Germany; H3 Pharma Inc., Montreal, PQ, Canada; Department of Surgery, University of Würzburg, Würzburg, Germany
| |
Collapse
|
4
|
Abstract
The ability of the antipsoriatic anthralin to induce HaCaT keratinocyte differentiation was investigated and correlated with its potency to inhibit proliferation of keratinocytes. To determine the structural requirements for this effect, anthralin and seventeen simple analogues or related anthracenones were examined for their ability to induce the formation of cornified envelope as a marker of terminal differentiation. Covalently cross-linked protein was measured as a key feature of this process. Induction of keratinocyte differentiation was significant at a concentration of 0.5 microM anthralin after 48 h exposure. The presence of the 1,8-dihydroxy groups is a critical determinant of cross-linking activity, since removing or exchanging these groups prevented the induction of keratinocyte differentiation. Furthermore, at least one hydrogen atom at the 10-position of anthralin is required. Moreover, anthralin, anthralin dimer, and anthralin triacetate exhibited antiproliferative and antirespiratory activity at concentrations required to induce keratinocyte differentiation, suggesting a causality between these effects. In addition, cornified envelope formation was observed for a number of related anthracenones at concentrations as low as 1-5 microM. In general, compounds containing benzoyl substituents, independent of the position in the anthralin nucleus, were more potent than those having benzyl substituents. Only marginal differences in cross-linking potency were observed within a number of phenylpropionyl substituted analogues, suggesting that the ability to induce keratinocyte differentiation is independent of the nature of substituents at the side chain.
Collapse
Affiliation(s)
- K Müller
- Westfälische Wilhelms-Universität Münster, Institut für Pharmazeutische Chemie, Hittorfstrasse 58-62, D-48149 Münster, Germany
| | | |
Collapse
|